Andrew D. Dickinson - 29 Nov 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Financial Officer
Signature
/s/ Amy Kim by Power of Attorney for Andrew D. Dickinson
Issuer symbol
GILD
Transactions as of
29 Nov 2024
Transactions value $
-$5,536,694
Form type
4
Filing time
03 Dec 2024, 14:43:20 UTC
Previous filing
11 Sep 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $1.37M +18.6K +13.41% $73.77 158K 29 Nov 2024 Direct F1
transaction GILD Common Stock Options Exercise $1.52M +26.2K +16.61% $57.92 184K 29 Nov 2024 Direct F1
transaction GILD Common Stock Options Exercise $2.31M +33.7K +18.32% $68.75 217K 29 Nov 2024 Direct F1
transaction GILD Common Stock Options Exercise $4.38M +60.9K +28.01% $71.91 278K 29 Nov 2024 Direct F1
transaction GILD Common Stock Options Exercise $3.15M +43.3K +15.58% $72.70 322K 29 Nov 2024 Direct F1
transaction GILD Common Stock Options Exercise $4.8M +66K +20.51% $72.70 388K 29 Nov 2024 Direct F1
transaction GILD Common Stock Sale -$11.2M -121K -31.15% $92.77 267K 29 Nov 2024 Direct F1, F2
transaction GILD Common Stock Sale -$11.9M -128K -47.94% $92.76 139K 29 Nov 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -26.2K -16.67% $0.00 131K 29 Nov 2024 Common Stock 26.2K $57.92 Direct F1, F4
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -18.6K -100% $0.00 0 29 Nov 2024 Common Stock 18.6K $73.77 Direct F1, F5
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -33.7K -100% $0.00 0 29 Nov 2024 Common Stock 33.7K $68.75 Direct F1, F4
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -60.9K -100% $0.00 0 29 Nov 2024 Common Stock 60.9K $71.91 Direct F1, F4
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -43.3K -100% $0.00 0 29 Nov 2024 Common Stock 43.3K $72.70 Direct F1, F5
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -66K -100% $0.00 0 29 Nov 2024 Common Stock 66K $72.70 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
F2 Sales prices reported for the transactions reported here range from $92.36 to $93.09. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F3 Sales prices reported for the transactions reported here range from $92.33 to $93.09. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4 The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F5 The shares subject to the option have a three year vesting schedule. 33.33% vest on the first anniversary of the date of the grant. The balance will vest 8.33% quarterly thereafter until fully vested.